亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        胰腺癌患者血漿miR-155檢測及其診斷價(jià)值

        2011-11-21 10:47:31劉建強(qiáng)高軍李兆申任艷王小瑋王衛(wèi)衛(wèi)路華
        中華胰腺病雜志 2011年2期
        關(guān)鍵詞:胰腺癌敏感性特異性

        劉建強(qiáng) 高軍 李兆申 任艷 王小瑋 王衛(wèi)衛(wèi) 路華

        ·論著·

        胰腺癌患者血漿miR-155檢測及其診斷價(jià)值

        劉建強(qiáng) 高軍 李兆申 任艷 王小瑋 王衛(wèi)衛(wèi) 路華

        目的檢測胰腺癌患者血漿miR-155表達(dá)量,評(píng)價(jià)其對(duì)胰腺癌的診斷價(jià)值。方法收集62例胰腺癌、61例慢性胰腺炎(CP)及36例正常對(duì)照者的血標(biāo)本,抽提血漿RNA,應(yīng)用實(shí)時(shí)PCR檢測miR-155表達(dá)量,并分析其與胰腺癌臨床參數(shù)的關(guān)系。應(yīng)用接受者操作特征(ROC)曲線下面積(AUC)評(píng)價(jià)血漿miR-155表達(dá)量對(duì)胰腺癌的診斷價(jià)值。結(jié)果胰腺癌、CP和正常對(duì)照組的血漿miR-155表達(dá)量分別為5.41±3.14、2.59±2.49和0.77±1.17,胰腺癌血漿miR-155表達(dá)量顯著高于CP及正常對(duì)照組(P<0.01 )。胰腺癌血漿miR-155表達(dá)量與患者年齡、性別、腫瘤大小等均無顯著相關(guān)性,而與腫瘤TNM分期呈顯著負(fù)相關(guān)(r=-0.323,P=0.01)。經(jīng)ROC分析,胰腺癌對(duì)正常對(duì)照組的AUC為0.943(95%CI0.902~0.985),敏感性和特異性分別為87.1%和83.3%;胰腺癌對(duì)CP的AUC為0.762(95%CI0.678~0.846),敏感性和特異性分別為64.5%和73.8%;胰腺癌對(duì)正常對(duì)照組+CP組的AUC為0.829(95%CI0.767~0.892),敏感性和特異性分別為62.9%和84.5%。結(jié)論胰腺癌患者血漿miR-155表達(dá)量顯著升高,對(duì)胰腺癌的診斷可能有一定的應(yīng)用價(jià)值。

        胰腺腫瘤; 微RNA; 診斷

        血清CA19-9對(duì)胰腺癌的診斷敏感性為70%~80%[1],而特異性不到50%[2],這就需要發(fā)現(xiàn)新的胰腺癌腫瘤標(biāo)志物。眾多研究結(jié)果表明,microRNA(miRNA)與腫瘤的發(fā)病及預(yù)后相關(guān),其中miR-155在胰腺癌組織中顯著高表達(dá)[3]。本研究檢測胰腺癌患者血漿miR-155表達(dá)量,評(píng)價(jià)其對(duì)胰腺癌的診斷價(jià)值。

        資料和方法

        一、臨床資料

        收集2008年1月至2009年12月第二軍醫(yī)大學(xué)附屬長海醫(yī)院收治的62例胰腺癌患者和61例慢性胰腺炎(CP)患者的血漿標(biāo)本。所有胰腺癌患者均經(jīng)手術(shù)及病理證實(shí)。CP患者通過影像學(xué)診斷,并隨訪半年以上無腫瘤發(fā)生者。以36例年齡匹配、無任何腫瘤病史的健康體檢者作為正常對(duì)照組。

        二、血漿miR-155檢測

        采集2 ml外周靜脈血,置EDTA試管抗凝,4℃離心取上層血漿至1.5 ml Eppendorf管, 4℃ 12 000 g離心10 min后置-80℃保存。取200 μl血漿,加入5 μl作為內(nèi)參的50 pmol/L的線蟲miR-39(Qiagen公司),再加入20 μl 5 mol/L醋酸和750 μl TRI Regent BD(Molecular Research Center),按TRI Regent BD說明書抽提RNA。取2 μl RNA用TaqMan MicroRNA 逆轉(zhuǎn)錄試劑盒(Applied Biosystems公司)獲取cDNA,反應(yīng)條件:16℃ 30 min,42℃ 30 min,85℃ 5 min,4℃ 維持。取2 μl cDNA作為模板,用TaqMan Universal Master Mix Ⅱ試劑盒進(jìn)行實(shí)時(shí) PCR,miR-155和miR-39探針為TaqMan公司提供。PCR條件:95℃ 1 min,95℃ 15 s,60℃ 30 s,50個(gè)循環(huán)。每份標(biāo)本設(shè)3個(gè)復(fù)孔。采用ABI 7500實(shí)時(shí)定量PCR儀進(jìn)行檢測,用SDS 2.1軟件計(jì)算標(biāo)本Ct值。miR-155表達(dá)量=-△△Ct=-[(Ct患者-Ct患者miR-39)-(Ct對(duì)照標(biāo)本-Ct對(duì)照miR-39)]。

        三、統(tǒng)計(jì)學(xué)處理

        結(jié) 果

        一、一般情況

        62例胰腺癌患者中,男42例,女20例,中位年齡62歲(36~79歲)。其中胰頭癌43例,胰體尾癌19例。TNM分期Ⅰ期10例,Ⅱ期15例,Ⅲ期14例,Ⅳ期23例。61例CP患者中,男44例,女17例,中位年齡48歲(19~76歲)。36例對(duì)照者中,男20例,女16例,中位年齡49歲(25~68歲)。

        二、血漿miR-155表達(dá)量

        胰腺癌、CP、對(duì)照組血漿miR-155表達(dá)量分別為5.41±3.14、2.59±2.49和0.77±1.17,胰腺癌組顯著高于CP組及對(duì)照組(P<0.01)。CP組血漿miRNA表達(dá)量雖高于對(duì)照組,但無統(tǒng)計(jì)學(xué)意義。

        三、血漿miR-155水平與胰腺癌臨床病理參數(shù)的關(guān)系

        血漿miR-155水平與胰腺癌患者年齡、性別、CA19-9水平、腫瘤最大直徑、局部淋巴結(jié)和遠(yuǎn)處轉(zhuǎn)移均無顯著相關(guān)性,但與T分期和臨床TNM分期呈顯著負(fù)相關(guān)(P<0.05,表1)。

        表1 血漿miRNA表達(dá)量與胰腺癌臨床參數(shù)的關(guān)系

        注:a:pearson相關(guān)分析,其他采用spearman秩相關(guān)分析

        四、血漿miR-155表達(dá)量對(duì)胰腺癌的診斷價(jià)值

        根據(jù)logistic回歸模型,血漿miR-155診斷胰腺癌的AUC及診斷敏感性、特異性、準(zhǔn)確性、陽性預(yù)測值、陰性預(yù)測值見表2。血漿miR-155表達(dá)量在鑒別胰腺癌與對(duì)照組時(shí)的敏感性和特異性較高。

        表2 血漿miR-155對(duì)胰腺癌的診斷價(jià)值

        討 論

        miRNA是一類內(nèi)源性的非編碼調(diào)控單鏈小分子RNA,長度約18~25個(gè)核苷酸,通過對(duì)mRNA的調(diào)控,參與細(xì)胞增殖、分化、凋亡和代謝等過程的調(diào)節(jié)[4],目前已可預(yù)測哺乳動(dòng)物約30%基因表達(dá)的miRNA調(diào)控靶點(diǎn)[5]。通常情況下,miRNA通過沉默基因表達(dá)而調(diào)控細(xì)胞功能,其表達(dá)異常可導(dǎo)致腫瘤等疾病的發(fā)生[6-7]。已經(jīng)證實(shí),miRNA在結(jié)腸癌、乳腺癌和肺癌等腫瘤中起負(fù)調(diào)控作用[8-9],在血液系統(tǒng)淋巴瘤和白血病中miRNA異常表達(dá)[10-11]。

        MiR-155在甲狀腺癌[12]、乳腺癌[2]、結(jié)腸癌[10]和胰腺導(dǎo)管腺癌[13-14]等腫瘤中高表達(dá),并在腫瘤發(fā)生中起癌基因的作用[15]。研究表明,在胰腺癌早期腫瘤蛋白53誘導(dǎo)核蛋白1(TP53INP1)缺失,而miR-155參與了TP53INP1的轉(zhuǎn)錄后調(diào)控。胰腺癌細(xì)胞株轉(zhuǎn)染miR-155后伴有TP53INP1缺失[16]。本結(jié)果顯示,胰腺癌患者血漿miR-155表達(dá)量顯著高于CP患者和對(duì)照組,CP患者血漿miR-155表達(dá)量也顯著高于對(duì)照組,與正常胰腺到CP,再發(fā)展為胰腺癌的規(guī)律相符,提示miR-155具有胰腺癌的腫瘤特異性。血漿miR-155水平與胰腺癌大小、是否局部淋巴結(jié)和遠(yuǎn)處轉(zhuǎn)移等臨床參數(shù)之間無顯著相關(guān)性,而與腫瘤的T分期和臨床TNM分期呈負(fù)相關(guān),這是否表示腫瘤浸潤胰腺周邊組織及血管者伴隨血漿miR-155的降低還需進(jìn)一步研究證實(shí)。通過logistic回歸及ROC曲線分析,血漿miR-155對(duì)胰腺癌診斷的敏感性和特異性較理想,有一定的臨床應(yīng)用價(jià)值。

        [1] Slesak B, Harlozinska-Szmyrka A, Knast W, et al. Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9. Cancer,2000,89: 83-88.

        [2] Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res,2005,65:7065-7070.

        [3] Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA,2007,297:1901-1908.

        [4] Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell,2004,116: 281-297.

        [5] Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet,2008,9:102-114.

        [6] Slack FJ, Weidhaas JB. MicroRNA in cancer prognosis. N Engl J Med,2008,359:2720-2722.

        [7] Visone R, Croce CM. MiRNAs and cancer. Am J Pathol,2009,174:1131-1138.

        [8] Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature,2005,435:834-838.

        [9] Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA,2006,103:2257-2261.

        [10] Calin GA, Liu CG, Sevignani C, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA,2004,101:11755-11760.

        [11] Lawrie CH, Soneji S, Marafioti T, et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer,2007,121:1156-1161.

        [12] Nikiforova MN, Tseng GC, Steward D, et al. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab,2008,93:1600-1608.

        [13] Lee EJ, Gusev Y, Jiang J, et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer,2007,120:1046-1054.

        [14] Szafranska AE, Davison TS, John J, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene,2007,26:4442-4452.

        [15] Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer,2006,6:259-269.

        [16] Gironella M, Seux M, Xie MJ, et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci USA,2007,104:16170-16175.

        (本文編輯:呂芳萍)

        DiagnosticvalueofplasmamiR55forpancreaticcancer

        LIUJian-qiang,GAOJun,LIZhao-shen,RENYan,WANGXiao-wei,WANGWei-wei,LUHua.

        DepartmentofGastroenterology,ChanghaiHospital,SecondMilitaryMedicalUniversity,Shanghai200433,China

        LIZhao-shen,lizhaoshen@yahoo.com

        ObjectiveTo detect the level of plasma miR-155 in patients with pancreatic cancer and evaluate its diagnostic value for pancreatic cancer.MethodsSixty-two cases of pancreatic cancer patients, 61 patients of chronic pancreatitis and 36 normal controls were included in the study. miR-155 in the total RNA extracted from the plasma was measured using real time PCR. The diagnostic parameters and relationship of the miR-155 with clinical characteristics in pancreatic cancer patients were analyzed.ResultsThe relative abundance of plasma miR-155 in pancreatic cancer, chronic pancreatitis and normal controls were 5.41±3.14,2.59±2.49 and 0.77±1.17, and the value was significantly higher in pancreatic cancer group compared with those of chronic pancreatitis and normal group (P<0.01). No significant correlation between the level of plasma miR-155 and age, sex, tumor size in pancreatic cancer patients was found. But there was a negative correlation between the level of plasma miR-155 and TNM staging (r=-0.323,P=0.01). For discriminating pancreatic cancer from normal control, the AUC ROC of miR-155 was 0.943 (95%CI0.902-0.985), and the sensitivity and specificity were87.1% and 83.3%, respectively. For discriminating pancreatic cancer from chronic pancreatitis, the AUC ROC of miR-155 was 0.762 (95%CI0.678-0.846), and the sensitivity and specificity were 64.5% and 73.8%, respectively. For discriminating pancreatic cancer from chronic pancreatitis and normal, the AUC-ROC of miR-155 was 0.829(95%CI0.767-0.892), and the sensitivity and specificity were 62.9% and 84.5%, respectively.ConclusionsPlasma miR-155 was

        共同第一作者:高軍

        significantly increased in patients with pancreatic cancer, and can be used for diagnosis of pancreatic cancer.

        Pancreatic neoplasms; MicroRNAs; Diagnosis

        10.3760/cma.j.issn.1674-1935.2011.02.001

        國家科技支撐計(jì)劃資助項(xiàng)目(2006BAI02A12)

        200433 上海,第二軍醫(yī)大學(xué)附屬長海醫(yī)院消化內(nèi)科

        李兆申,Email:lizhaoshen@yahoo.com

        2010-12-29)

        猜你喜歡
        胰腺癌敏感性特異性
        胰腺癌治療為什么這么難
        釔對(duì)Mg-Zn-Y-Zr合金熱裂敏感性影響
        精確制導(dǎo) 特異性溶栓
        STAT1和MMP-2在胰腺癌中表達(dá)的意義
        BOPIM-dma作為BSA Site Ⅰ特異性探針的研究及其應(yīng)用
        AH70DB鋼焊接熱影響區(qū)組織及其冷裂敏感性
        焊接(2016年1期)2016-02-27 12:55:37
        重復(fù)周圍磁刺激治療慢性非特異性下腰痛的臨床效果
        早診早治趕走胰腺癌
        如何培養(yǎng)和提高新聞敏感性
        新聞傳播(2015年8期)2015-07-18 11:08:24
        兒童非特異性ST-T改變
        国产福利小视频91| 欧美精品videossex少妇| 一本色道av久久精品+网站| 91久久国产综合精品| 亚洲av熟女天堂久久天堂| 白嫩丰满少妇av一区二区| 亚洲成人色区| 男人j进女人p免费视频| 在线播放偷拍一区二区| 亚洲综合极品美女av| 欧美成人午夜精品久久久| 久久久久亚洲AV无码专| 91桃色在线播放国产| 女人被狂躁的高潮免费视频| 欧美日韩国产成人高清视频| 全免费a级毛片免费看| 麻豆成年人视频在线观看| 婷婷四虎东京热无码群交双飞视频 | 久久久精品亚洲一区二区国产av| 两个人看的www免费视频中文| 中文字幕日韩高清| 日本一区二区三区在线视频观看 | 色吧综合网| 最新亚洲av日韩av二区一区| 亚洲伦理第一页中文字幕| 国产无人区码一码二码三mba| 亚洲V无码一区二区三区四区观看 久久精品国产亚洲综合色 | 97中文字幕一区二区| 免费一级淫片日本高清| 中国老熟妇自拍hd发布| 香蕉国产人午夜视频在线观看| 小黄片免费在线播放观看| 久久伊人少妇熟女大香线蕉| 亚洲av成人一区二区三区av | 亚州av高清不卡一区二区| 中国老熟女重囗味hdxx| 色丁香在线观看| 日韩av在线免费观看不卡| 无码无套少妇毛多18p| 亚洲欧洲精品成人久久曰影片| 国产91AV免费播放|